These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30108543)

  • 1. Deep Brain Stimulation in Moroccan Patients With Parkinson's Disease: The Experience of Neurology Department of Rabat.
    Rahmani M; Benabdeljlil M; Bellakhdar F; Faris MEA; Jiddane M; Bayad KE; Boutbib F; Razine R; Gana R; Hassani MRE; Fatemi NE; Fikri M; Sanhaji S; Tassine H; Balrhiti IEA; Hadri SE; Kettani NE; Abbadi NE; Amor M; Moussaoui A; Semlali A; Aidi S; Benhaddou EHA; Benomar A; Bouhouche A; Yahyaoui M; Khamlichi AE; Ouahabi AE; Maaqili RE; Tibar H; Arkha Y; Melhaoui A; Benazzouz A; Regragui W
    Front Neurol; 2018; 9():532. PubMed ID: 30108543
    [No Abstract]   [Full Text] [Related]  

  • 2. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
    Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of unilateral subthalamic deep brain stimulation in highly asymmetrical Parkinson's disease: 7-year follow-up.
    Ehm G; Kim HJ; Kim JY; Lee JY; Kim HJ; Yun JY; Kim YE; Yang HJ; Lim YH; Jeon B; Paek SH
    J Neurosurg; 2019 Nov; 131(5):1508-1513. PubMed ID: 30497175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
    Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
    J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of LEDD and motor scores following STN-DBS treatment in patient with young onset vs. late onset Parkinson's disease.
    Park YS; Kim HY; Chang WS; Lee PH; Sohn YH; Chang JW
    Neuromodulation; 2010 Oct; 13(4):255-60. PubMed ID: 21992878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in advanced Parkinson's disease after bilateral subthalamic stimulation: 2 years follow-up study.
    Sobstyl M; Ząbek M; Górecki W; Mossakowski Z
    Clin Neurol Neurosurg; 2014 Sep; 124():161-5. PubMed ID: 25051167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthalamic deep brain stimulation and levodopa in Parkinson's disease: a meta-analysis of combined effects.
    Vizcarra JA; Situ-Kcomt M; Artusi CA; Duker AP; Lopiano L; Okun MS; Espay AJ; Merola A
    J Neurol; 2019 Feb; 266(2):289-297. PubMed ID: 29909467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal dopamine transporter availability and individual clinical course within the 1-year follow-up of deep brain stimulation of the subthalamic nucleus in patients with Parkinson's disease.
    Löser J; Luthardt J; Rullmann M; Weise D; Sabri O; Meixensberger J; Hesse S; Winkler D
    J Neurosurg; 2021 Nov; 135(5):1429-1435. PubMed ID: 33607613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dopaminergic therapy on intraoperative microelectrode recordings for subthalamic deep brain stimulation under GA: can we operate on patients 'on medications'?
    Asha MJ; Kausar J; Krovvidi H; Shirley C; White A; Chelvarajah R; Hodson JA; Pall H; Mitchell RD
    Acta Neurochir (Wien); 2016 Feb; 158(2):387-93. PubMed ID: 26602236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
    Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
    Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Subthalamic Deep Brain Stimulation on Levodopa-Induced Dyskinesia in Parkinson's Disease.
    Kim JH; Chang WS; Jung HH; Chang JW
    Yonsei Med J; 2015 Sep; 56(5):1316-21. PubMed ID: 26256974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of subthalamic nucleus stimulation did not differ on young-onset and older-onset Parkinson's disease: A three-year follow up.
    Zhang J; Jia G; Yang Z; Liu D; Hou Y; Wang Y; Yang Z
    Neurosci Lett; 2019 Jul; 705():99-105. PubMed ID: 31028845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of Advanced Parkinson's Disease Manifestations with Deep Brain Stimulation of the Subthalamic Nucleus: A Single Institution Experience.
    Rabie A; Verhagen Metman L; Fakhry M; Eassa AY; Fouad W; Shakal A; Slavin KV
    Brain Sci; 2016 Dec; 6(4):. PubMed ID: 27983589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease.
    Drapier S; Raoul S; Drapier D; Leray E; Lallement F; Rivier I; Sauleau P; Lajat Y; Edan G; Vérin M
    J Neurol; 2005 May; 252(5):583-8. PubMed ID: 15778909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of bilateral deep brain stimulation in the subthalamic nucleus using two methods of target structure verification].
    Goubareva NN; Fedorova NV; Bril' EV; Tomskiy AA; Gamaleya AA; Poddubskaya AA; Shabalov VA; Omarova SM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):24-30. PubMed ID: 29265083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson's disease: a meta-analysis of randomized controlled trials.
    Tan ZG; Zhou Q; Huang T; Jiang Y
    Clin Interv Aging; 2016; 11():777-86. PubMed ID: 27382262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.